Introduction

Innopharm GmbH

The license holder and the owner of the technical documentation of Medistus® Antivirus lozenges is the Innopharm GmbH in Austria.
In 2018 Innopharm GmbH received ISO 13485 certification, which makes it a qualified producer of medical devices. The main activity of the company encompasses the trading and distribution of medical devices.
The production of Medistus® Antivirus lozenges takes place according to DIN EN ISO and GMP standards at the production site of a highly recognized pharmaceutical manufacturer in Germany using strictly controlled natural substances.
The exclusive rights for worldwide distribution are conferred upon the Vitaplus Kft in Hungary owing to its long-term experience and extensive network of commercial partners. Medistus® Antivirus was introduced by Vitaplus Kft in numerous countries in Europe and in Overseas and has successfully been distributed there ever since. On behalf of the Innopharm GmbH it is the Vitaplus Kft which shall represent the trademark and the product Medistus® Antivirus on international trade fairs and exhibitions.
The Innopharm GmbH provides all necessary clinical studies and laboratory tests which are essential for the safety and efficacy of its medical devices. Furthermore, the Innopharm GmbH is the head of product development and innovation.
Concerning product development, the Innopharm GmbH is supported not only by its own innovation management but also by its long-term German partner in quality assurance and in product development. Beyond the existing connections in Germany and Austria, the Innopharm GmbH is permanently on the quest for new business relationships for the realization of further projects and developments.